サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1756483

免疫組織化学市場：オファリング別、用途別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測

Immunohistochemistry Market, By Offering, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 387 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
免疫組織化学市場：オファリング別、用途別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測
出版日: 2025年05月23日
発行: AnalystView Market Insights
ページ情報: 英文 387 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

免疫組織化学市場規模は2024年に28億7,600万米ドルとなり、2024～2032年にかけてCAGR 6.6%で拡大

免疫組織化学市場-市場力学

慢性疾患の増加

慢性疾患、特にがんの罹患率の増加は免疫組織化学市場の主要促進要因です。IHCは、組織サンプル中の特定のバイオマーカーを検出することにより、がんの正確な診断と分類に重要な役割を果たしています。これによって個別化された治療計画が可能になり、患者の転帰が改善されます。人口の高齢化やライフスタイルの要因により、世界のがん罹患率やその他の慢性疾患が増加するにつれ、IHCのような精密な診断技術に対する需要が高まっています。さらに、研究開発や医薬品開発におけるIHCの利用拡大が、標的治療や精密医療の進歩をサポートすることで、開発をさらに後押ししています。

免疫組織化学市場-主要な洞察

当社のリサーチアナリストによると、世界の免疫組織化学市場は、2024～2032年の間に約6.6％のCAGRで発展する見込みです。

2023年の市場セグメンテーションでは、抗体カテゴリーが市場を独占しています。

用途別では、診断用途セグメントが2023年に最も収益を上げました。

地域別では、2023年に北米が最も収益の高い地域でした。

免疫組織化学市場-セグメンテーション分析

世界の免疫組織化学市場は4つのカテゴリーに分類されます：オファリング、用途、エンドユーザー、地域。

免疫組織化学（IHC）市場は、オファリング別に抗体、試薬、機器、キット、ソフトウェアに区分されます。抗体は、組織サンプル中の標的抗原と特異的に結合するために不可欠であり、IHCプロセスにおいて重要なコンポーネントです。試薬は染色と可視化の様々な段階をサポートし、機器には顕微鏡、スライドスキャナー、検査の実施と分析に使用される自動染色システムが含まれます。キットは抗体と試薬を組み合わせてすぐに使用でき、ラボのワークフローを簡素化します。ソフトウェアソリューションは画像分析やデータ管理を支援し、精度と効率を高めています。これらのセグメントの中で、抗体は、バイオマーカーの同定における基本的な役割、多様で特異性の高い抗体への高い需要、継続的な技術革新により、市場を独占しており、世界中の診断・研究用途で大きな収益と採用を牽引しています。

免疫組織化学（IHC）市場は、用途別に診断用途、研究用途、法医学用途に分類されます。診断用途とは、患者組織サンプル中の特異的バイオマーカーを検出することにより、疾患、特にがんを同定・分類するためにIHC技術を使用することです。研究用途では、ラボや学術的な環境において、IHCを用いて疾患メカニズムの研究、医薬品開発、バイオマーカー探索を行います。法医学用途では、犯罪捜査において組織型や細胞成分の同定にIHCが使用されます。これらのうち、診断用途は、特に腫瘍学において、正確かつ早期の疾患検出の必要性が高まっていることから、市場で最大のシェアを占めています。慢性疾患の有病率の上昇と個別化医療の普及が、臨床診断におけるIHCの需要を強く牽引しており、世界的に主要な用途セグメントとなっています。

免疫組織化学市場-地理的洞察

地域的には、免疫組織化学市場は北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカに分布しています。これらの地域は、ビジネスをもたらしている国々に基づいてさらに分割されます。

北米は免疫組織化学市場において支配的な地域であり、先進的ヘルスケアインフラ、革新的な診断技術の高い採用率、大規模な研究投資がその原動力となっています。大手製薬会社やバイオテクノロジー会社の存在と、がんや慢性疾患研究のための政府からの強力な資金援助が市場成長を後押ししています。さらに、個別化医療と早期疾患診断に対する意識の高まりが、IHC技術の普及を後押ししています。米国は、精密な診断ツールに対する旺盛な需要、確立された償還施策、大規模な患者プールで地域をリードしており、北米を世界の免疫組織化学市場における主要な収益貢献国としています。

欧州が免疫組織化学市場で大きなシェアを占めているのは、その発達したヘルスケアシステムとがんや他の慢性疾患の有病率の増加によるものです。ドイツ、英国、フランスのような国々は、政府のイニシアチブと研究資金に支えられて、先進的なIHC技術を採用する最前線にいます。精密医療への注目の高まりとバイオ医薬品研究活動の拡大が需要をさらに押し上げています。欧州はまた、診断ラボや学術機関の強力なネットワークの恩恵を受けており、臨床診断と研究目的の両方におけるIHCの使用を促進し、世界的に支配的な地域市場として位置づけられています。

免疫組織化学市場-競合情勢

免疫組織化学市場は、Thermo Fisher Scientific、Danaher Corporation、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratoriesのような老舗企業によって支配されています。これらの企業は技術革新、品質、規制遵守に重点を置き、臨床診断や研究用の抗体、試薬、キット、機器の幅広いポートフォリオを提供しています。これらの企業は、製品の感度と特異性を高めるために研究開発に多額の投資を行っており、個別化医療と正確な疾患検出に対する需要の高まりに対応しています。また、新興企業も新規技術の開発で貢献しており、IHC手法の継続的な改善を促進し、世界中の医療研究セグメントでの採用を拡大する競合を促進しています。

目次

第1章 免疫組織化学市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 免疫組織化学の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 免疫組織化学産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 免疫組織化学市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 免疫組織化学市場情勢

  • 免疫組織化学市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • ベテラン選手の分析
    • 新興企業の分析

第7章 免疫組織化学市場-オファリング別

  • 概要
    • オファリング別セグメントシェア分析
    • 抗体
      • 一次抗体
      • 二次抗体
      • モノクローナル抗体
      • ポリクローナル抗体
    • 試薬
      • 組織学的染色
      • ブロッキング血清と試薬
      • 発色基質
      • 固定試薬
      • 希釈剤
      • 有機溶剤
      • タンパク質分解酵素
      • その他の試薬
    • 機器
      • スライド染色システム
      • 組織処理システム
      • スライドスキャナー
      • その他の機器
    • キット
      • ヒト免疫組織化学キット
      • 動物免疫組織化学キット
    • ソフトウェア

第8章 免疫組織化学市場-用途別

  • 概要
    • 用途別セグメントシェア分析
    • 診断用途
      • がん
      • 感染症
      • 腎臓疾患
      • 自己免疫疾患
      • 神経疾患
      • その他
    • 研究用途
      • 医薬品の開発と検査
      • その他の研究用途
    • 法医学用途

第9章 免疫組織化学市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院と診断ラボ
    • 学術研究機関と契約研究機関
    • その他

第10章 免疫組織化学市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-免疫組織化学産業

  • 競合ダッシュボード
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • Agilent Technologies, Inc
    • Thermo Fisher Scientific Inc.
    • Merck Kgaa
    • Bio-Rad Laboratories, Inc
    • Bio-Techne
    • Becton, Dickinson And Company
    • Takara Bio Inc.
    • Enzo Biochem Inc.
    • Sino Biological, Inc.
    • Sakura Finetek Japan Co., Ltd.
    • Cell Signaling Technology, Inc.
    • Bio Sb
    • Origene Technologies, Inc
    • Eaglebio
    • Biocare Medical, Llc
    • Elabscience Bionovation Inc.
    • Biogenex
    • Diagnostic Biosystems Inc.
    • Histo-Line Laboratories
    • Rockland Immunochemicals, Inc.
    • Candor Bioscience Gmbh
    • Genemed BIoTechnologies, Inc.
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV5291

REPORT HIGHLIGHT

Immunohistochemistry Market size was valued at USD 2,876 Million in 2024, expanding at a CAGR of 6.6% from 2024 to 2032.

The Immunohistochemistry (IHC) market refers to the industry focused on the production and sale of reagents, antibodies, detection kits, instruments, and related services used for IHC techniques. Immunohistochemistry is a laboratory method that uses antibodies to detect specific antigens in tissue samples, aiding in disease diagnosis, especially cancer, and research. The market encompasses products used in hospitals, diagnostic labs, research institutes, and pharmaceutical companies. Growth in this market is driven by rising prevalence of chronic diseases, technological advancements, and increasing demand for personalized medicine and accurate diagnostic tools globally.

Immunohistochemistry Market- Market Dynamics

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases, especially cancer, is a major driver of the immunohistochemistry market. IHC plays a crucial role in accurately diagnosing and classifying cancers by detecting specific biomarkers in tissue samples. This enables personalized treatment plans and better patient outcomes. As global cancer rates and other chronic illnesses grow due to aging populations and lifestyle factors, the demand for precise diagnostic techniques like IHC increases. Additionally, the expanding use of IHC in research and drug development further propels market growth by supporting advancements in targeted therapies and precision medicine.

Immunohistochemistry Market- Key Insights

According to our research analyst, the global Immunohistochemistry Market is expected to develop at a CAGR of approximately 6.6% between 2024-2032.

Segmented by Offerings in 2023, the Antibodies category dominated the market.

Based on Application, the Diagnostic Applications segment generated the most income in 2023.

On the basis of region, in 2023, North America was the region with the highest revenue.

Immunohistochemistry Market- Segmentation Analysis:

The global Immunohistochemistry Market is divided into Four categories: Offering, Application, End User, and Region.

The Immunohistochemistry (IHC) market is segmented by offering into Antibodies, Reagents, Equipment, Kits, and Software. Antibodies are essential for specifically binding to target antigens in tissue samples, making them a critical component in IHC processes. Reagents support various stages of staining and visualization, while Equipment includes microscopes, slide scanners, and automated staining systems used to perform and analyze tests. Kits provide ready-to-use combinations of antibodies and reagents, simplifying workflows for laboratories. Software solutions aid in image analysis and data management, enhancing accuracy and efficiency. Among these segments, Antibodies dominate the market due to their fundamental role in identifying biomarkers, high demand for diverse and highly specific antibodies, and continuous innovations, which drive significant revenue and adoption across diagnostic and research applications worldwide.

The Immunohistochemistry (IHC) market is categorized by application into Diagnostic Applications, Research Applications, and Forensic Applications. Diagnostic applications represent the use of IHC techniques to identify and classify diseases, particularly cancers, by detecting specific biomarkers in patient tissue samples. Research applications involve studying disease mechanisms, drug development, and biomarker discovery using IHC in laboratories and academic settings. Forensic applications use IHC for identifying tissue types and cellular components in criminal investigations. Among these, Diagnostic Applications hold the largest share of the market due to the growing need for precise and early disease detection, especially in oncology. The rising prevalence of chronic diseases and increasing adoption of personalized medicine strongly drive the demand for IHC in clinical diagnostics, making it the dominant application segment globally.

Immunohistochemistry Market- Geographical Insights

Geographically, the Immunohistochemistry Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Immunohistochemistry market, driven by advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and significant research investments. The presence of major pharmaceutical and biotechnology companies, coupled with strong government funding for cancer and chronic disease research, fuels market growth. Additionally, increasing awareness about personalized medicine and early disease diagnosis supports widespread use of IHC techniques. The U.S. leads the region with robust demand for precise diagnostic tools, well-established reimbursement policies, and a large patient pool, making North America a key revenue contributor in the global immunohistochemistry market.

Europe holds a significant share in the Immunohistochemistry market due to its well-developed healthcare systems and increasing prevalence of cancer and other chronic diseases. Countries like Germany, the UK, and France are at the forefront of adopting advanced IHC technologies, supported by government initiatives and research funding. The rising focus on precision medicine and expanding biopharmaceutical research activities further drive demand. Europe also benefits from a strong network of diagnostic laboratories and academic institutions, promoting the use of IHC for both clinical diagnostics and research purposes, positioning it as a dominant regional market globally.

Immunohistochemistry Market- Competitive Landscape:

The Immunohistochemistry market is dominated by established players like Thermo Fisher Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories. These companies focus heavily on innovation, quality, and regulatory compliance, offering a broad portfolio of antibodies, reagents, kits, and instruments for clinical diagnostics and research. They invest substantially in R&D to enhance product sensitivity and specificity, catering to the growing demand for personalized medicine and accurate disease detection. Emerging companies also contribute by developing novel technologies, driving competition that fosters continuous improvement in IHC methodologies and expands adoption in healthcare and research sectors worldwide.

Recent Developments:

In March 2025, Thermo Fisher Scientific Inc. launched a new automated IHC staining platform designed to improve throughput and reproducibility in clinical laboratories.

In December 2024, Danaher Corporation acquired a leading digital pathology software firm to enhance its IHC image analysis capabilities and integrate AI-driven diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOHISTOCHEMISTRY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Agilent Technologies, Inc
  • Thermo Fisher Scientific Inc.
  • Merck Kgaa
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Becton, Dickinson And Company
  • Takara Bio Inc.
  • Enzo Biochem Inc.
  • Sino Biological, Inc.
  • Sakura Finetek Japan Co., Ltd.
  • Cell Signaling Technology, Inc.
  • Bio Sb
  • Origene Technologies, Inc
  • Eaglebio
  • Biocare Medical, Llc
  • Elabscience Bionovation Inc.
  • Biogenex
  • Diagnostic Biosystems Inc.
  • Histo-Line Laboratories
  • Rockland Immunochemicals, Inc.
  • Candor Bioscience Gmbh
  • Genemed Biotechnologies, Inc.
  • Others

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING - MARKET ANALYSIS, 2019 - 2032

  • Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Reagents
  • Histological Stains
  • Blocking Sera And Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Diluents
  • Organic Solvents
  • Proteolytic Enzymes
  • Other Reagents
  • Equipment
  • Slide-Staining Systems
  • Tissue Processing Systems
  • Slide Scanners
  • Other Equipment
  • Kits
  • Human Immunohistochemistry Kits
  • Animal Immunohistochemistry Kits
  • Software

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Applications
  • Cancer
  • Infectious Diseases
  • Nephrological Diseases
  • Autoimmune Diseases
  • Neurological Diseases
  • Other Diseases
  • Research Applications
  • Drug Development And Testing
  • Other Research Applications
  • Forensic Applications

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals And Diagnostic Laboratories
  • Academic & Research Institutes And Contract Research Organizations
  • Other End Users

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Immunohistochemistry Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunohistochemistry Market Snippet by Offerings
    • 2.1.2. Immunohistochemistry Market Snippet by Application
    • 2.1.3. Immunohistochemistry Market Snippet by End User
    • 2.1.4. Immunohistochemistry Market Snippet by Country
    • 2.1.5. Immunohistochemistry Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunohistochemistry Key Market Trends

  • 3.1. Immunohistochemistry Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunohistochemistry Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunohistochemistry Market Opportunities
  • 3.4. Immunohistochemistry Market Future Trends

4. Immunohistochemistry Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunohistochemistry Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immunohistochemistry Market Landscape

  • 6.1. Immunohistochemistry Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunohistochemistry Market - By Offerings

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Offerings, 2023 & 2032 (%)
    • 7.1.2. Antibodies
      • 7.1.2.1. Primary Antibodies
      • 7.1.2.2. Secondary Antibodies
      • 7.1.2.3. Monoclonal Antibodies
      • 7.1.2.4. Polyclonal Antibodies
    • 7.1.3. Reagents
      • 7.1.3.1. Histological Stains
      • 7.1.3.2. Blocking Sera And Reagents
      • 7.1.3.3. Chromogenic Substrates
      • 7.1.3.4. Fixation Reagents
      • 7.1.3.5. Diluents
      • 7.1.3.6. Organic Solvents
      • 7.1.3.7. Proteolytic Enzymes
      • 7.1.3.8. Other Reagents
    • 7.1.4. Equipment
      • 7.1.4.1. Slide-Staining Systems
      • 7.1.4.2. Tissue Processing Systems
      • 7.1.4.3. Slide Scanners
      • 7.1.4.4. Other Equipment
    • 7.1.5. Kits
      • 7.1.5.1. Human Immunohistochemistry Kits
      • 7.1.5.2. Animal Immunohistochemistry Kits
    • 7.1.6. Software

8. Immunohistochemistry Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Diagnostic Applications
      • 8.1.2.1. Cancer
      • 8.1.2.2. Infectious Diseases
      • 8.1.2.3. Nephrological Diseases
      • 8.1.2.4. Autoimmune Diseases
      • 8.1.2.5. Neurological Diseases
      • 8.1.2.6. Other Diseases
    • 8.1.3. Research Applications
      • 8.1.3.1. Drug Development and Testing
      • 8.1.3.2. Other Research Applications
    • 8.1.4. Forensic Applications

9. Immunohistochemistry Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals And Diagnostic Laboratories
    • 9.1.3. Academic & Research Institutes and Contract Research Organizations
    • 9.1.4. Other End Users

10. Immunohistochemistry Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Immunohistochemistry Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Immunohistochemistry Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Immunohistochemistry Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Immunohistochemistry Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Immunohistochemistry Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Immunohistochemistry Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd
    • 11.2.2. Danaher Corporation
    • 11.2.3. Agilent Technologies, Inc
    • 11.2.4. Thermo Fisher Scientific Inc.
    • 11.2.5. Merck Kgaa
    • 11.2.6. Bio-Rad Laboratories, Inc
    • 11.2.7. Bio-Techne
    • 11.2.8. Becton, Dickinson And Company
    • 11.2.9. Takara Bio Inc.
    • 11.2.10. Enzo Biochem Inc.
    • 11.2.11. Sino Biological, Inc.
    • 11.2.12. Sakura Finetek Japan Co., Ltd.
    • 11.2.13. Cell Signaling Technology, Inc.
    • 11.2.14. Bio Sb
    • 11.2.15. Origene Technologies, Inc
    • 11.2.16. Eaglebio
    • 11.2.17. Biocare Medical, Llc
    • 11.2.18. Elabscience Bionovation Inc.
    • 11.2.19. Biogenex
    • 11.2.20. Diagnostic Biosystems Inc.
    • 11.2.21. Histo-Line Laboratories
    • 11.2.22. Rockland Immunochemicals, Inc.
    • 11.2.23. Candor Bioscience Gmbh
    • 11.2.24. Genemed Biotechnologies, Inc.
    • 11.2.25. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us